KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Clover Health Investments (CLOV) Net Cash Flow (2020 - 2025)

Clover Health Investments (CLOV) has disclosed Net Cash Flow for 6 consecutive years, with -$103.1 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Net Cash Flow fell 125.17% year-over-year to -$103.1 million, compared with a TTM value of -$107.6 million through Dec 2025, down 263.94%, and an annual FY2025 reading of -$62.9 million, down 195.74% over the prior year.
  • Net Cash Flow was -$103.1 million for Q4 2025 at Clover Health Investments, down from $1.4 million in the prior quarter.
  • Across five years, Net Cash Flow topped out at $312.2 million in Q1 2021 and bottomed at -$283.5 million in Q3 2021.
  • Average Net Cash Flow over 5 years is $2.1 million, with a median of $28.7 million recorded in 2024.
  • Peak annual rise in Net Cash Flow hit 3634.86% in 2021, while the deepest fall reached 1503.41% in 2021.
  • Year by year, Net Cash Flow stood at $97.7 million in 2021, then plummeted by 301.28% to -$196.7 million in 2022, then rose by 10.88% to -$175.2 million in 2023, then skyrocketed by 73.86% to -$45.8 million in 2024, then crashed by 125.17% to -$103.1 million in 2025.
  • Business Quant data shows Net Cash Flow for CLOV at -$103.1 million in Q4 2025, $1.4 million in Q3 2025, and $33.2 million in Q2 2025.